Neuroendoscopy Market Size, Share, and Trends 2025 to 2034

The global neuroendoscopy market is projected to grow from USD 170.12 million in 2025 to USD 273.52 million by 2034, registering a CAGR of 5.42%. Rising neurological disorders, a preference for minimally invasive treatments, and innovations in imaging and surgical techniques are fueling market expansion worldwide.

Last Updated : July 2025  |  Report Code : 4008  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Neuroendoscopy Market 

5.1. COVID-19 Landscape: Neuroendoscopy Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Neuroendoscopy Market, By Product

8.1. Neuroendoscopy Market Revenue and Volume, by Product

8.1.1. Rigid Neuroendoscopes

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Flexible Neuroendoscopes

8.1.2.1. Market Revenue and Volume Forecast

Chapter 9. Global Neuroendoscopy Market, By Usability

9.1. Neuroendoscopy Market Revenue and Volume, by Usability

9.1.1. Reusable Neuroendoscopes

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Disposable Neuroendoscopes

9.1.2.1. Market Revenue and Volume Forecast

Chapter 10. Global Neuroendoscopy Market, By Patient 

10.1. Neuroendoscopy Market Revenue and Volume, by Patient

10.1.1. Adult

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Pediatric

10.1.2.1. Market Revenue and Volume Forecast

Chapter 11. Global Neuroendoscopy Market, By Application

11.1. Neuroendoscopy Market Revenue and Volume, by Application

11.1.1. Transnasal Endoscopy

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Intraventricular Endoscopy

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Transcranial Endoscopy

11.1.3.1. Market Revenue and Volume Forecast

Chapter 12. Global Neuroendoscopy Market, By End-Use

12.1. Neuroendoscopy Market Revenue and Volume, by End-Use

12.1.1. Hospitals

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Ambulatory Surgical Center

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Diagnostic Center

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Others

12.1.4.1. Market Revenue and Volume Forecast

Chapter 13. Global Neuroendoscopy Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product

13.1.2. Market Revenue and Volume Forecast, by Usability

13.1.3. Market Revenue and Volume Forecast, by Patient

13.1.4. Market Revenue and Volume Forecast, by Application

13.1.5. Market Revenue and Volume Forecast, by End-Use

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product

13.1.6.2. Market Revenue and Volume Forecast, by Usability

13.1.6.3. Market Revenue and Volume Forecast, by Patient

13.1.6.4. Market Revenue and Volume Forecast, by Application

13.1.6.5. Market Revenue and Volume Forecast, by End-Use  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product

13.1.7.2. Market Revenue and Volume Forecast, by Usability

13.1.7.3. Market Revenue and Volume Forecast, by Patient

13.1.7.4. Market Revenue and Volume Forecast, by Application

13.1.7.5. Market Revenue and Volume Forecast, by End-Use

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product

13.2.2. Market Revenue and Volume Forecast, by Usability

13.2.3. Market Revenue and Volume Forecast, by Patient

13.2.4. Market Revenue and Volume Forecast, by Application  

13.2.5. Market Revenue and Volume Forecast, by End-Use  

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product

13.2.6.2. Market Revenue and Volume Forecast, by Usability

13.2.6.3. Market Revenue and Volume Forecast, by Patient

13.2.7. Market Revenue and Volume Forecast, by Application  

13.2.8. Market Revenue and Volume Forecast, by End-Use  

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product

13.2.9.2. Market Revenue and Volume Forecast, by Usability

13.2.9.3. Market Revenue and Volume Forecast, by Patient

13.2.10. Market Revenue and Volume Forecast, by Application

13.2.11. Market Revenue and Volume Forecast, by End-Use

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product

13.2.12.2. Market Revenue and Volume Forecast, by Usability

13.2.12.3. Market Revenue and Volume Forecast, by Patient

13.2.12.4. Market Revenue and Volume Forecast, by Application

13.2.13. Market Revenue and Volume Forecast, by End-Use

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product

13.2.14.2. Market Revenue and Volume Forecast, by Usability

13.2.14.3. Market Revenue and Volume Forecast, by Patient

13.2.14.4. Market Revenue and Volume Forecast, by Application

13.2.15. Market Revenue and Volume Forecast, by End-Use

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product

13.3.2. Market Revenue and Volume Forecast, by Usability

13.3.3. Market Revenue and Volume Forecast, by Patient

13.3.4. Market Revenue and Volume Forecast, by Application

13.3.5. Market Revenue and Volume Forecast, by End-Use

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product

13.3.6.2. Market Revenue and Volume Forecast, by Usability

13.3.6.3. Market Revenue and Volume Forecast, by Patient

13.3.6.4. Market Revenue and Volume Forecast, by Application

13.3.7. Market Revenue and Volume Forecast, by End-Use

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product

13.3.8.2. Market Revenue and Volume Forecast, by Usability

13.3.8.3. Market Revenue and Volume Forecast, by Patient

13.3.8.4. Market Revenue and Volume Forecast, by Application

13.3.9. Market Revenue and Volume Forecast, by End-Use

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product

13.3.10.2. Market Revenue and Volume Forecast, by Usability

13.3.10.3. Market Revenue and Volume Forecast, by Patient

13.3.10.4. Market Revenue and Volume Forecast, by Application

13.3.10.5. Market Revenue and Volume Forecast, by End-Use

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product

13.3.11.2. Market Revenue and Volume Forecast, by Usability

13.3.11.3. Market Revenue and Volume Forecast, by Patient

13.3.11.4. Market Revenue and Volume Forecast, by Application

13.3.11.5. Market Revenue and Volume Forecast, by End-Use

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product

13.4.2. Market Revenue and Volume Forecast, by Usability

13.4.3. Market Revenue and Volume Forecast, by Patient

13.4.4. Market Revenue and Volume Forecast, by Application

13.4.5. Market Revenue and Volume Forecast, by End-Use

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product

13.4.6.2. Market Revenue and Volume Forecast, by Usability

13.4.6.3. Market Revenue and Volume Forecast, by Patient

13.4.6.4. Market Revenue and Volume Forecast, by Application

13.4.7. Market Revenue and Volume Forecast, by End-Use

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product

13.4.8.2. Market Revenue and Volume Forecast, by Usability

13.4.8.3. Market Revenue and Volume Forecast, by Patient

13.4.8.4. Market Revenue and Volume Forecast, by Application

13.4.9. Market Revenue and Volume Forecast, by End-Use

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product

13.4.10.2. Market Revenue and Volume Forecast, by Usability

13.4.10.3. Market Revenue and Volume Forecast, by Patient

13.4.10.4. Market Revenue and Volume Forecast, by Application

13.4.10.5. Market Revenue and Volume Forecast, by End-Use

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product

13.4.11.2. Market Revenue and Volume Forecast, by Usability

13.4.11.3. Market Revenue and Volume Forecast, by Patient

13.4.11.4. Market Revenue and Volume Forecast, by Application

13.4.11.5. Market Revenue and Volume Forecast, by End-Use

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product

13.5.2. Market Revenue and Volume Forecast, by Usability

13.5.3. Market Revenue and Volume Forecast, by Patient

13.5.4. Market Revenue and Volume Forecast, by Application

13.5.5. Market Revenue and Volume Forecast, by End-Use

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product

13.5.6.2. Market Revenue and Volume Forecast, by Usability

13.5.6.3. Market Revenue and Volume Forecast, by Patient

13.5.6.4. Market Revenue and Volume Forecast, by Application

13.5.7. Market Revenue and Volume Forecast, by End-Use

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product

13.5.8.2. Market Revenue and Volume Forecast, by Usability

13.5.8.3. Market Revenue and Volume Forecast, by Patient

13.5.8.4. Market Revenue and Volume Forecast, by Application

13.5.8.5. Market Revenue and Volume Forecast, by End-Use

Chapter 14. Company Profiles

14.1. Foncepi Comercial Exportadora Ltd

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. B. Braun

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Karl Storz

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Olympus Corporation

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Stryker

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Medtronic

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Ackermann Instruments GmbH

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Adeor Medical AG

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Clarus Medical LLC

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Machida Endoscope

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global neuroendoscopy market size is expected to increase USD 273.52 million by 2034 from USD 161.30 million in 2024.

The global neuroendoscopy market will register growth rate of 5.42% between 2025 and 2034.

The major players operating in the neuroendoscopy market are Foncepi Comercial Exportadora Ltd, B. Braun, Karl Storz, Olympus Corporation, Stryker, Medtronic, Ackermann Instruments GmbH, Adeor Medical AG, Clarus Medical LLC, Machida Endoscope, Tonglu WANHE Medical Instrument, Hawk, Schindler Endoskopie Technologie GmbH, and Others.

The driving factors of the neuroendoscopy market are the increasing prevalence of neurological disorders and rising incidence of conditions as brain tumors.

North America region will lead the global neuroendoscopy market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client